论文成果
The Role of Toll-like Receptor Agonists and Their Nanomedicines for Tumor Immunotherapy
  • 所属单位:
    药学院
  • 发表刊物:
    PHARMACEUTICS
  • 第一作者:
    Lingling Huang
  • 论文编号:
    294AB9A1758E464F9FE0A069C9478F63
  • 期号:
    6
  • 字数:
    8
  • 是否译文:
  • 发表时间:
    2022-07-10

上一条:Ferrocene-conjugated polymeric platform via amide bond formation facilitates enhanced in situ fenton reaction and robust immune responses in combination with toll-like receptor 7/8 agonist

下一条:In Situ Tumor Vaccination with Calcium-Linked Degradable Coacervate Nanocomplex Co-Delivering Photosensitizer and TLR7/8 Agonist to Trigger Effective Anti-Tumor Immune Responses

版权所有   ©山东大学 地址:中国山东省济南市山大南路27号 邮编:250100 
查号台:(86)-0531-88395114
值班电话:(86)-0531-88364731 建设维护:山东大学信息化工作办公室